Oral cancer drug repurposed to treat diabetes

Researchers have repurposed a cancer drug, a focal adhesion kinase inhibitor, to treat diabetes by converting acinar cells into insulin-producing cells. A study in animal models — diabetic mice and a nonhuman primate — showed improved blood glucose regulation after a three-week course of the drug. Promising long-term benefits were observed, suggesting potential as a new diabetes treatment approach.

Read more: Nature Communications

The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.